Postbooster Antibodies from Humans as Source of Diphtheria Antitoxin

Diphtheria antitoxin for therapeutic use is in limited supply. A potential source might be affinity-purified antibodies originally derived from plasma of adults who received a booster dose of a vaccine containing diphtheria toxoid. These antibodies might be useful for treating even severe cases of d...

Descripción completa

Detalles Bibliográficos
Autores principales: Bermejo-Martin, Jesús F., Avila-Alonso, Ana, González-Rivera, Milagros, Tamayo, Eduardo, Eiros, Jose María, Almansa, Raquel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2016
Materias:
Dispatch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918160/
https://www.ncbi.nlm.nih.gov/pubmed/27314309
http://dx.doi.org/10.3201/eid2207.151670
Descripción
Sumario:Diphtheria antitoxin for therapeutic use is in limited supply. A potential source might be affinity-purified antibodies originally derived from plasma of adults who received a booster dose of a vaccine containing diphtheria toxoid. These antibodies might be useful for treating even severe cases of diphtheria.

Ejemplares similares